BIOTIME 8-K 5-5-2010

Company

Lineage Cell Therapeutics, Inc.

Filed

May 5, 2010

Period of Report

May 5, 2010

Accession Number

0001140361-10-018967

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →